Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
Medientyp
Sprache
Region
Erscheinungszeitraum
Zugriff
  • 1
    Online-Ressource
    Online-Ressource
    Cham :Springer International Publishing :
    Dazugehörige Titel
    UID:
    almahu_9949882747302882
    Umfang: XXIX, 247 p. 109 illus., 92 illus. in color. , online resource.
    Ausgabe: 1st ed. 2024.
    ISBN: 9783031504150
    Serie: AAPS Advances in the Pharmaceutical Sciences Series, 60
    Inhalt: Despite being an economically intense activity, the current state of drug product development makes a limited effort to integrate economics into product design and development. For example, pharmaceutical scientists are excellent at a data-driven decision-making process that requires technical elements and a few strategic elements. However, there is minimal integration of financial valuation elements (commonly employed in other high tech industries such as fine chemicals, automotive, aerospace, etc.) into pharmaceutical drug development. Unfortunately, this hurts the sustainability of the health system of which these products will be a part in the future. A desirable future state is the one that integrates fundamentals of economics in product design and development so that the decision-making is parameterized, the cost of goods could be lowered, wastage can be reduced, patient-centricity is built into the design, and manufacturing/distribution efficiencies can be gained. The financial benefits of such an approach could allow for these savings to be passed on to the stakeholders and improve the value proposition of pharmaceuticals, which is critical to maintaining the innovation potential. This book hopes to introduce the reader to this desired future state of pharmaceutical drug development. .
    Anmerkung: Health Care Industry -- Reimbursement and Pricing -- Current Stage of Pharmaceutical Development -- Desired Future State of Pharmaceutical Development -- Case Studies I -- Case Studies II -- Case Studies III.
    In: Springer Nature eBook
    Weitere Ausg.: Printed edition: ISBN 9783031504143
    Weitere Ausg.: Printed edition: ISBN 9783031504167
    Weitere Ausg.: Printed edition: ISBN 9783031504174
    Sprache: Englisch
    URL: Volltext  (URL des Erstveröffentlichers)
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Online-Ressource
    Online-Ressource
    Cham :Springer International Publishing :
    Dazugehörige Titel
    UID:
    almafu_9961675766502883
    Umfang: 1 online resource (268 pages)
    Ausgabe: 1st ed. 2024.
    ISBN: 3-031-50415-1
    Serie: AAPS Advances in the Pharmaceutical Sciences Series, 60
    Inhalt: Despite being an economically intense activity, the current state of drug product development makes a limited effort to integrate economics into product design and development. For example, pharmaceutical scientists are excellent at a data-driven decision-making process that requires technical elements and a few strategic elements. However, there is minimal integration of financial valuation elements (commonly employed in other high tech industries such as fine chemicals, automotive, aerospace, etc.) into pharmaceutical drug development. Unfortunately, this hurts the sustainability of the health system of which these products will be a part in the future. A desirable future state is the one that integrates fundamentals of economics in product design and development so that the decision-making is parameterized, the cost of goods could be lowered, wastage can be reduced, patient-centricity is built into the design, and manufacturing/distribution efficiencies can be gained. The financial benefits of such an approach could allow for these savings to be passed on to the stakeholders and improve the value proposition of pharmaceuticals, which is critical to maintaining the innovation potential. This book hopes to introduce the reader to this desired future state of pharmaceutical drug development. .
    Anmerkung: Health Care Industry -- Reimbursement and Pricing -- Current Stage of Pharmaceutical Development -- Desired Future State of Pharmaceutical Development -- Case Studies I -- Case Studies II -- Case Studies III.
    Weitere Ausg.: ISBN 3-031-50414-3
    Sprache: Englisch
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Meinten Sie 9783031104183?
Meinten Sie 9783031207143?
Meinten Sie 9783031108143?
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz